Here are relevant reports on : bone-graft-substitute-market
-
US Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs) - Forecast to 2031
The US Periodontal Disease Treatment market, valued at USD 0.65 billion in 2025, stood at USD 0.68 billion in 2026 and is projected to advance at a resilient CAGR of 5.5% from 2026 to 2031, culminating in a forecasted valuation of USD 0.94 billion by the end of the period. Periodontal disease treatment in the US encompasses a wide range of technologies and solutions designed to support the diagnosis, treatment, and long-term management of gum-related conditions in dental practices.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Hematology Testing Market byTest [CBC (Hemoglobin, Hematocrit, & RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, & DPG], End User (& Clinical Testing Labs, Research Institute, & Hospital) - Global Forecasts to 2019
Emerging markets such as China, India, Brazil, and Mexico are the new revenue pockets for companies that are engaged in the development and marketing of hematology analyzers and reagents. Growing patient population, rising healthcare expenditure, and rising trends of medical tourism owing to low-cost treatments are the key factors propelling demand for hematology tests in these emerging nations.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Radioligand Therapy (RLT) Market by Product (Lutetium-177 Vipivotide Tetraxetan, (Lu-177)- PNT2002, Radium-223 dichloride), Target (PSMA, SSTR, Bone Metastases), Indication (Prostate Cancer, Neuroendocrine Tumors (NETS), SCLC) - Global Forecast to 2035
The global radioligand therapy market, valued at US$2.36 billion in 2024, stood at US$3.15 billion in 2025 and is projected to advance at a resilient CAGR of 13.2% from 2025 to 2035, culminating in a forecasted valuation of US$10.91 billion by the end of the period. The growth of this market is primarily attributed to factors such as increasing approvals and label expansions of RLT products, manufacturing scale-up, particularly for Lu-177 supply, and the rising adoption of PSMA and SSTR PET imaging for patient selection.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
ACL Graft Market by Type of ACL Surgery (Reconstruction, Revision), Age (Above & Below 19 years), Gender (Male, Female), Injury (Sports Injuries (Basketball, Football), Non-sports Injuries (Road Accidents, Falls)), End User - Global Forecast to 2029
The global ACL graft market, valued at US$0.11 billion in 2023, stood at US$0.12 billion in 2024 and is projected to advance at a resilient CAGR of 7.2% from 2024 to 2029, culminating in a forecasted valuation of US$0.18 billion by the end of the period. The market growth is primarily driven by the increasing age-related orthopedic complications, including ACL injuries, along with the growing geriatric population. Increased healthcare expenditure and the expansion of healthcare facilities globally are significant opportunities for market players.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Bone & Joint Health Supplements Market by Type (Vitamin D, Vitamin K, Calcium, Collagen, Omega 3-Fatty Acid, Glucosamine-Chondroitin), Distribution Channels, Form (Tablets, Capsules, Liquid, Powder), Target Consumers and Region - Global Forecast to 2027
The global bone and joint health supplements market is projected to reach USD 17.6 billion by 2027, recording a CAGR of 8.5% during the forecast period. The Major players in this market include Bayer AG(Germany), Procter & Gamble (US), Amway (US), Basf SE (Germany) and Archer Daniels Midland (US).
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Vitamin K2 Market by Product Type (MK-4, MK-7), Form (Capsules & Tablets, Powder & Crystalline, Oils & Liquid), Application (Pharmaceutical, Functional Food & Beverages, Health Supplements), by Function (Bone & Cardiovascular Health, Blood Health & Clotting, Anti-Inflammatory & Immune Support, Other Functions) - Global Forecast to 2029
The vitamin K2 market is projected to reach USD 264.7 million by 2029 and is poised to achieve a 13.7% CAGR during the forecasting period. The key players in the market are Gnosis By Lesaffre (Nattopharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-Oil Mills, Inc. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), Richen (China), Menadiona (Spain), and GENOFOCUS (South Korea).
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Aspiration & Biopsy Needles Market by Product (Aspiration Needle, CNB, VAB), Application (Breast, Lung, Bone Cancer), Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Non-image-guided), End User (Hospital, ASC, Academia) & Region - Global Forecast to 2027
The global aspiration needles market in terms of revenue was estimated to be worth $879 million in 2021 and is poised to reach $1,303 million by 2027, growing at a CAGR of 6.8% from 2021 to 2027. Factors such as the rising prevalence of cancer, initiatives undertaken by the government and global health organizations, and the increasing preference for minimally invasive procedures are the major factors driving the growth of the aspiration and biopsy needle market.
- Published: February 2022
- Price: $ 4950
- TOC Available:
-
Cell Isolation Market / Cell Separation Market Size, Share & Trends by Product (Consumables [Media, Kits] Instruments), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose Tissue), Technique (Centrifugation, Filtration), Application (Biomolecule, Cancer) - Global Forecast to 2029
The global cell isolation market, valued at US$4.2 billion in 2023, stood at US$4.6 billion in 2024 and is projected to advance at a resilient CAGR of 12.9% from 2024 to 2029, culminating in a forecasted valuation of US$8.4 billion by the end of the period. The growth of the market can be attributed to the growing focus on technology advancement along with the development of new products that are more economical, technologically advanced, and easy to use.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Transplant Diagnostics Market Size, Share & Trends by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User & Region - Global Forecast to 2028
The global transplant diagnostics market, valued at US$4.1 billion in 2021, stood at US$4.4 billion in 2022 and is projected to advance at a resilient CAGR of 7.4% from 2023 to 2028, culminating in a forecasted valuation of US$6.8 billion by the end of the period. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: April 2023
- Price: $ 4950
- TOC Available:
-
Joint Replacement Devices Market by Product (Knee, Hip, Shoulder, Ankle, Elbow, Wrist, Bone Grafts), Surgery (Total, Partial, Revision), Type(Cemented, Cementless, Hybrid), Procedure type, End user (Hospitals, ASC, Trauma, Clinic) - Global Forecast to 2030
Global joint replacement devices market valued at $22.50B in 2023, reached $23.42B in 2024, and is projected to grow at a robust 4.8% CAGR, hitting $31.09B by 2030. Market growth can be attributed to factors such as increasing prevalence of orthopedic disorders, increasing demand for minimally invasive orthopedic surgical procedures, and rising number of sport injuries
- Published: February 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
